Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS
Contenido archivado el 2024-05-29

Developing a stem cell based therapy to replace nephrons lost through reflux nephropathy

Objetivo

The aim of this project is to design a stem cell-based therapy to prevent end-stage renal disease caused by reflux nephropathy in children. The two main reasons to focus on this condition are that it is the major cause of kidney failure in children and young adults and secondly, the disease typically takes several years to reach end stage, allowing time for therapies to repair damage kidneys before they become completely non-functional. Recent advances in stem cell science and tissue engineering present an unprecedented opportunity to design a stem cell therapy for this clinical problem.
This project will investigate the properties of several different stem cell types (embryonic stem cells, kidney stem cells, amniotic fluid stem cells and mesenchymal stem cells) in order to determine which is most appropriate for the generation of functional kidney tissue. To do this, novel biomaterials will be designed that will provide a substrate both for the generation of kidney progenitor cells and for their transplantation.

Ámbito científico (EuroSciVoc)

Tema(s)

Convocatoria de propuestas

FP6-2005-MOBILITY-1
Consulte otros proyectos de esta convocatoria

Régimen de financiación

RTN - Marie Curie actions-Research Training Networks

Coordinador

THE UNIVERSITY OF LIVERPOOL
Aportación de la UE
Sin datos
Coste total
Sin datos

Participantes (5)